SEC Filing Analysis: Bunge Global SA (BG)

Executive Summary

• Trading Significance: High
• Key Takeaway: Bunge has released detailed pro forma financials for its $10.6B acquisition of Viterra, revealing a combined entity with nearly $90B in pro forma annual revenue.
• Market Impact: Neutral to Positive (Validates the scale of the merger, though the dilution and debt load are now explicitly detailed).

Company Information

Field	Value
Company	Bunge Global SA
Ticker Symbol	BG
CIK	0001996862
Industry	Agricultural Inputs & Processing

Transaction Details

Field	Value
Form Type	8-K
Filing Date	2026-03-17
Transaction Type	Acquisition (Pro Forma Financials)
Shares Issued	~65,600,000
Price Per Share	$81.39 (at closing)
Total Consideration	$10,617,000,000

Financial Impact Assessment

Transaction Materiality

Metric	Value
Total Consideration	$10.62 Billion
% of Market Cap	43.98%
Shares Issued	65.6 Million
% of Shares Outstanding	33.90%
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: With a market cap of $24.14B, this $10.6B transaction is transformational, representing nearly 44% of the company's value.
• Dilution Impact: The issuance of ~65.6 million shares represents a massive ~34% dilution relative to the current 193.5M shares outstanding. The pro forma weighted average shares outstanding for 2025 is calculated at ~199M (diluted).
• Financial Structure: The deal included $1.88B in cash consideration and the assumption/repayment of $3.55B in Viterra debt, significantly altering Bunge's leverage profile.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The acquisition closed in July 2025, so the market has likely priced in the deal itself. However, these specific pro forma numbers provide the first detailed look at the combined accounting, including depreciation adjustments and interest expenses, which could lead to analyst model revisions.

Volume & Sentiment

• Expected Volume Impact: Moderate. Institutional investors will digest the pro forma data to update valuation models.
• Sentiment Indicator: Neutral. The revenue scale ($89.5B pro forma) is impressive, but net income attributable to shareholders ($650M pro forma for 2025) reflects the heavy impact of transaction costs and interest expenses.

Investment Insights

Key Takeaways

1. Massive Scale: The combined entity shows pro forma 2025 net sales of $89.5 billion, cementing Bunge's position as a top-tier global agribusiness leader.
2. Dilution & Debt: The filing confirms significant dilution (34% of float) and a heavier debt load, with pro forma interest expense rising to $819 million for 2025.
3. Integration Costs: The pro forma income statement reflects substantial adjustments, including $754 million in intercompany eliminations and significant transaction-related costs, highlighting the complexity of integrating Viterra.

Additional Context

Transaction Notes

• Timing: While the filing is dated March 2026, it relates to the acquisition closed on July 2, 2025. This is a regulatory filing to provide the required financial statements.
• Divestitures: The pro forma financials exclude results from required divestitures in Hungary and Poland (EU Oilseeds Divestment) to satisfy regulatory conditions.